| Literature DB >> 35318511 |
Ara Aboolian1, Sofia Urner1, Michael Roden2,1,3, Jay Chandra Jha4, Karin Jandeleit-Dahm5,6.
Abstract
One of the microvascular complications of diabetes is diabetic kidney disease (DKD), often leading to end stage renal disease (ESRD) in which patients require costly dialysis or transplantation. The silent onset and irreversible progression of DKD are characterized by a steady decline of the estimated glomerular filtration rate, with or without concomitant albuminuria. The diabetic milieu allows the complex pathophysiology of DKD to enter a vicious cycle by inducing the synthesis of excessive amounts of reactive oxygen species (ROS) causing oxidative stress, inflammation, and fibrosis. As no cure is available, intensive research is required to develop novel treatments possibilities. This chapter provides an overview of the important pathomechanisms identified in diabetic kidney disease, the currently established therapies, as well as recently developed novel therapeutic strategies in DKD.Entities:
Keywords: Diabetic kidney disease; Diabetic nephropathy; Fibrosis; Inflammation; NADPH oxidase; Oxidative stress
Mesh:
Year: 2022 PMID: 35318511 DOI: 10.1007/164_2021_576
Source DB: PubMed Journal: Handb Exp Pharmacol ISSN: 0171-2004